APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral PrEP

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Parenteral PrEP Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchParenteral PrEP Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral PrEP Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Parenteral PrEP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral PrEP Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral PrEP Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Parenteral PrEP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parenteral PrEP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Parenteral PrEP market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Parenteral PrEP market include Gilead Sciences and ViiV Healthcare among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Parenteral PrEP market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Parenteral PrEP and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Parenteral PrEP sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parenteral PrEP market size, projected growth trends, production technologies, key applications, and end-use industries.

Parenteral PrEP Segment by Company

Gilead Sciences

ViiV Healthcare

Parenteral PrEP Segment by Type

Cabotegravir

Lenacapavir

Other

Parenteral PrEP Segment by Application

Subcutaneous Use

Intramuscular Use

Parenteral PrEP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Parenteral PrEP status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Parenteral PrEP market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Parenteral PrEP significant trends, drivers, influence factors in global and regions.

6. To analyze Parenteral PrEP competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral PrEP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral PrEP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral PrEP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Parenteral PrEP market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Parenteral PrEP industry.

Chapter 3: Detailed analysis of Parenteral PrEP manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Parenteral PrEP in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Parenteral PrEP in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Parenteral PrEP Industry Trends Table 2. Parenteral PrEP Industry Drivers Table 3. Parenteral PrEP Industry Opportunities and Challenges Table 4. Parenteral PrEP Industry Restraints Table 5. Global Parenteral PrEP Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Parenteral PrEP Revenue Share by Company (2021-2026) Table 7. Global Parenteral PrEP Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Parenteral PrEP Sales Volume Share by Company (2021-2026) Table 9. Global Parenteral PrEP Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Parenteral PrEP Company Ranking, (2024-2026) & (USD Million) Table 11. Global Parenteral PrEP Key Company Manufacturing Base & Headquarters Table 12. Global Parenteral PrEP Company, Product Type & Application Table 13. Global Parenteral PrEP Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Parenteral PrEP by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Cabotegravir Table 18. Significant Companies of Lenacapavir Table 19. Significant Companies of Other Table 20. Global Parenteral PrEP Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Parenteral PrEP Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Parenteral PrEP Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Parenteral PrEP Sales Volume Share by Type (2021-2026) Table 24. Global Parenteral PrEP Sales Volume Share by Type (2027-2032) Table 25. Global Parenteral PrEP Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Parenteral PrEP Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Parenteral PrEP Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Parenteral PrEP Sales Value Share by Type (2021-2026) Table 29. Global Parenteral PrEP Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Subcutaneous Use Table 31. Significant Companies of Intramuscular Use Table 32. Global Parenteral PrEP Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Parenteral PrEP Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Parenteral PrEP Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Parenteral PrEP Sales Volume Share by Application (2021-2026) Table 36. Global Parenteral PrEP Sales Volume Share by Application (2027-2032) Table 37. Global Parenteral PrEP Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Parenteral PrEP Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Parenteral PrEP Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Parenteral PrEP Sales Value Share by Application (2021-2026) Table 41. Global Parenteral PrEP Sales Value Share by Application (2027-2032) Table 42. Global Parenteral PrEP Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Parenteral PrEP Sales by Region (2021-2026) & (K Units) Table 44. Global Parenteral PrEP Sales Market Share by Region (2021-2026) Table 45. Global Parenteral PrEP Sales by Region (2027-2032) & (K Units) Table 46. Global Parenteral PrEP Sales Market Share by Region (2027-2032) Table 47. Global Parenteral PrEP Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Parenteral PrEP Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Parenteral PrEP Sales Value Share by Region (2021-2026) Table 50. Global Parenteral PrEP Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Parenteral PrEP Sales Value Share by Region (2027-2032) Table 52. Global Parenteral PrEP Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Parenteral PrEP Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Parenteral PrEP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Parenteral PrEP Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Parenteral PrEP Sales by Country (2021-2026) & (K Units) Table 57. Global Parenteral PrEP Sales Market Share by Country (2021-2026) Table 58. Global Parenteral PrEP Sales by Country (2027-2032) & (K Units) Table 59. Global Parenteral PrEP Sales Market Share by Country (2027-2032) Table 60. Global Parenteral PrEP Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Parenteral PrEP Sales Value Market Share by Country (2021-2026) Table 62. Global Parenteral PrEP Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Parenteral PrEP Sales Value Market Share by Country (2027-2032) Table 64. Gilead Sciences Company Information Table 65. Gilead Sciences Business Overview Table 66. Gilead Sciences Parenteral PrEP Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Gilead Sciences Parenteral PrEP Product Portfolio Table 68. Gilead Sciences Recent Development Table 69. ViiV Healthcare Company Information Table 70. ViiV Healthcare Business Overview Table 71. ViiV Healthcare Parenteral PrEP Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. ViiV Healthcare Parenteral PrEP Product Portfolio Table 73. ViiV Healthcare Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Parenteral PrEP Distributors List Table 77. Parenteral PrEP Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Parenteral PrEP Product Image Figure 2. Global Parenteral PrEP Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral PrEP Sales Value (2021-2032) & (US$ Million) Figure 4. Global Parenteral PrEP Sales (2021-2032) & (K Units) Figure 5. Global Parenteral PrEP Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Parenteral PrEP Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Cabotegravir Image Figure 10. Lenacapavir Image Figure 11. Other Image Figure 12. Global Parenteral PrEP Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Parenteral PrEP Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Parenteral PrEP Sales Volume Share by Type (2021-2032) Figure 15. Global Parenteral PrEP Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Parenteral PrEP Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Parenteral PrEP Sales Value Share by Type (2021-2032) Figure 18. Subcutaneous Use Image Figure 19. Intramuscular Use Image Figure 20. Global Parenteral PrEP Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Parenteral PrEP Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Parenteral PrEP Sales Volume Share by Application (2021-2032) Figure 23. Global Parenteral PrEP Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Parenteral PrEP Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Parenteral PrEP Sales Value Share by Application (2021-2032) Figure 26. Global Parenteral PrEP Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Parenteral PrEP Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Parenteral PrEP Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Parenteral PrEP Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Parenteral PrEP Sales Value (2021-2032) & (US$ Million) Figure 31. North America Parenteral PrEP Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Parenteral PrEP Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Parenteral PrEP Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Parenteral PrEP Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Parenteral PrEP Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Parenteral PrEP Sales Value (2021-2032) & (US$ Million) Figure 37. South America Parenteral PrEP Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Parenteral PrEP Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Parenteral PrEP Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Parenteral PrEP Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Parenteral PrEP Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Parenteral PrEP Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Parenteral PrEP Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Parenteral PrEP Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Cabotegravir
  • Lenacapavir
  • Other
Applications
  • Subcutaneous Use
  • Intramuscular Use
Companies covered
  • Gilead Sciences
  • ViiV Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Parenteral PrEP Sales Value (2021-2032)
  4. 1.2.2 Global Parenteral PrEP Sales Volume (2021-2032)
  5. 1.2.3 Global Parenteral PrEP Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Parenteral PrEP Market Dynamics
  1. 2.1 Parenteral PrEP Industry Trends
  2. 2.2 Parenteral PrEP Industry Drivers
  3. 2.3 Parenteral PrEP Industry Opportunities and Challenges
  4. 2.4 Parenteral PrEP Industry Restraints
3 Parenteral PrEP Market by Company
  1. 3.1 Global Parenteral PrEP Company Revenue Ranking in 2025
  2. 3.2 Global Parenteral PrEP Revenue by Company (2021-2026)
  3. 3.3 Global Parenteral PrEP Sales Volume by Company (2021-2026)
  4. 3.4 Global Parenteral PrEP Average Price by Company (2021-2026)
  5. 3.5 Global Parenteral PrEP Company Ranking (2024-2026)
  6. 3.6 Global Parenteral PrEP Company Manufacturing Base and Headquarters
  7. 3.7 Global Parenteral PrEP Company Product Type and Application
  8. 3.8 Global Parenteral PrEP Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Parenteral PrEP Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Parenteral PrEP Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Parenteral PrEP Market by Type
  1. 4.1 Parenteral PrEP Type Introduction
  2. 4.1.1 Cabotegravir
  3. 4.1.2 Lenacapavir
  4. 4.1.3 Other
  5. 4.2 Global Parenteral PrEP Sales Volume by Type
  6. 4.2.1 Global Parenteral PrEP Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Parenteral PrEP Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Parenteral PrEP Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Parenteral PrEP Sales Value by Type
  10. 4.3.1 Global Parenteral PrEP Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Parenteral PrEP Sales Value by Type (2021-2032)
  12. 4.3.3 Global Parenteral PrEP Sales Value Share by Type (2021-2032)
5 Parenteral PrEP Market by Application
  1. 5.1 Parenteral PrEP Application Introduction
  2. 5.1.1 Subcutaneous Use
  3. 5.1.2 Intramuscular Use
  4. 5.2 Global Parenteral PrEP Sales Volume by Application
  5. 5.2.1 Global Parenteral PrEP Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Parenteral PrEP Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Parenteral PrEP Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Parenteral PrEP Sales Value by Application
  9. 5.3.1 Global Parenteral PrEP Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Parenteral PrEP Sales Value by Application (2021-2032)
  11. 5.3.3 Global Parenteral PrEP Sales Value Share by Application (2021-2032)
6 Parenteral PrEP Regional Sales and Value Analysis
  1. 6.1 Global Parenteral PrEP Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Parenteral PrEP Sales by Region (2021-2032)
  3. 6.2.1 Global Parenteral PrEP Sales by Region: 2021-2026
  4. 6.2.2 Global Parenteral PrEP Sales by Region (2027-2032)
  5. 6.3 Global Parenteral PrEP Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Parenteral PrEP Sales Value by Region (2021-2032)
  7. 6.4.1 Global Parenteral PrEP Sales Value by Region: 2021-2026
  8. 6.4.2 Global Parenteral PrEP Sales Value by Region (2027-2032)
  9. 6.5 Global Parenteral PrEP Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Parenteral PrEP Sales Value (2021-2032)
  12. 6.6.2 North America Parenteral PrEP Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Parenteral PrEP Sales Value (2021-2032)
  15. 6.7.2 Europe Parenteral PrEP Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Parenteral PrEP Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Parenteral PrEP Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Parenteral PrEP Sales Value (2021-2032)
  21. 6.9.2 South America Parenteral PrEP Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Parenteral PrEP Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Parenteral PrEP Sales Value Share by Country, 2025 VS 2032
7 Parenteral PrEP Country-level Sales and Value Analysis
  1. 7.1 Global Parenteral PrEP Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Parenteral PrEP Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Parenteral PrEP Sales by Country (2021-2032)
  4. 7.3.1 Global Parenteral PrEP Sales by Country (2021-2026)
  5. 7.3.2 Global Parenteral PrEP Sales by Country (2027-2032)
  6. 7.4 Global Parenteral PrEP Sales Value by Country (2021-2032)
  7. 7.4.1 Global Parenteral PrEP Sales Value by Country (2021-2026)
  8. 7.4.2 Global Parenteral PrEP Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Parenteral PrEP Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Parenteral PrEP Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Parenteral PrEP Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Parenteral PrEP Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Parenteral PrEP Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Parenteral PrEP Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Parenteral PrEP Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Parenteral PrEP Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Parenteral PrEP Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Parenteral PrEP Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Parenteral PrEP Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Parenteral PrEP Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Parenteral PrEP Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Parenteral PrEP Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Parenteral PrEP Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Parenteral PrEP Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Parenteral PrEP Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Parenteral PrEP Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Parenteral PrEP Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Parenteral PrEP Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Parenteral PrEP Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Parenteral PrEP Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Parenteral PrEP Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Parenteral PrEP Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Parenteral PrEP Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Parenteral PrEP Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Parenteral PrEP Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Parenteral PrEP Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Parenteral PrEP Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Parenteral PrEP Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Gilead Sciences
  2. 8.1.1 Gilead Sciences Company Information
  3. 8.1.2 Gilead Sciences Business Overview
  4. 8.1.3 Gilead Sciences Parenteral PrEP Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Gilead Sciences Parenteral PrEP Product Portfolio
  6. 8.1.5 Gilead Sciences Recent Developments
  7. 8.2 ViiV Healthcare
  8. 8.2.1 ViiV Healthcare Company Information
  9. 8.2.2 ViiV Healthcare Business Overview
  10. 8.2.3 ViiV Healthcare Parenteral PrEP Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ViiV Healthcare Parenteral PrEP Product Portfolio
  12. 8.2.5 ViiV Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Parenteral PrEP Value Chain Analysis
  2. 9.1.1 Parenteral PrEP Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Parenteral PrEP Sales Mode & Process
  6. 9.2 Parenteral PrEP Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Parenteral PrEP Distributors
  9. 9.2.3 Parenteral PrEP Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst